CClinicalTrials.gg
RecruitingNCT05146349Updated Jan 24, 2022

Minnesota RETAIN Impact Evaluation

An interventional study of Minnesota RETAIN in Any Injury or Illness Acutely Impacting Work, sponsored by Mathematica Policy Research, Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-01-24.

Sponsored by Mathematica Policy Research, Inc. · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
3,200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. Collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay at work and return to work will be implemented.

Read the detailed description

MN RETAIN is a collaborative program led by the Minnesota Department of Employment and Economic Development (DEED), Minnesota Department of Health (MDH), Department of Labor and Industry (DLI), Mayo Clinic, and Workforce Development Inc (WDI) and includes stakeholders throughout MN.

02

Conditions studied

  • Any Injury or Illness Acutely Impacting Work

Browse trials for

Keywords

  • RETAIN
  • Minnesota RETAIN
  • MN RETAIN
  • illness recovery
  • injury recovery
  • out of work help
  • work placement assistance
  • job help
  • work help
  • help keeping my job
  • stay at work
  • return to work
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Must have been unable to work for no more than 6 months prior enrollment; 80% of participants must be within 3 months of their last day of work
  • 18 years or older
  • Minnesota resident
  • Works in Minnesota
  • Employed or currently in the labor force
  • Meets one of the following:

    1. Diagnosis of a work related or personal injury or illness that impacts employment
    2. Invasive procedure (e.g., surgery) within the past 12-weeks or anticipated within the next 8-weeks that impacts employment

Exclusion criteria

Exclusion Criteria:

  • Legal representation/litigation at the time of enrollment related to their medical condition.
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e. Mayo Clinic employees)
  • Worker's compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,200 participants (estimated)

Study arms

  • Experimental
    RETAIN Programming

    The experimental group receives the full set of RETAIN intervention activities.

    Other: Minnesota RETAIN

  • No intervention
    Control

    The control group does not receive the full set of RETAIN intervention activities.

Interventions

  • OtherMinnesota RETAIN

    RETAIN projects include a combination of medical provider services, stay-at-work/return-to-work (SAW/RTW) coordination services, and other SAW/RTW services. The evaluation compares the treatment group that is eligible to receive the full set of RETAIN intervention activities and an control group that is not.

05

What researchers measure

Primary outcomes

  1. Share of enrollees employed in the fourth quarter after enrollment

    Share of enrollees employed in the fourth quarter after enrollment obtained from state unemployment insurance wage records. These files include individual-level wage records for six quarters surrounding enrollment in the study, including the quarter prior to enrollment, the quarter of enrollment, and four post-enrollment quarters.

    Time frame: Measured in the fourth quarter after enrollment

  2. Enrollee earnings in the fourth quarter after enrollment

    Sum of enrollee earnings in the fourth quarter after enrollment obtained from state unemployment insurance wage records. These files include individual-level wage records for six quarters surrounding enrollment in the study, including the quarter prior to enrollment, the quarter of enrollment, and four post-enrollment quarters.

    Time frame: Measured in the fourth quarter after enrollment

  3. Share of enrollees that applied for SSDI or SSI during the 12 months after enrollment

    Share of enrollees that applied for SSDI or SSI during any of the 12 months after enrollment obtained from SSA program data. These files include detailed information about Social Security Disability Insurance (SSDI) and Supplemental Security Income (SSI) applications SSDI and SSI awards, SSDI and SSI benefit amounts and enrollee characteristics (for enrollees who have ever applied for SSA program benefits)

    Time frame: Measured in the 12 months after enrollment

06

Study locations

1 of 1 sites recruiting
  • Mn Retain, Mayo Clinic
    Rochester, Minnesota 55905, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05146349
Lead sponsor
Mathematica Policy Research, Inc.
Collaborators
Social Security Administration, Department of Labor and Industry, Minnesota Department of Health, Workforce Development, Inc.
Responsible party
Sponsor
First posted
Dec 6, 2021
Start date
Dec 23, 2021
Primary completion
Jun 2025 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
Jan 24, 2022

Study contacts

Amaka Osuoha, MPH
Contact
aosuoha@mathematica-mpr.com
734-205-3085
Catherine Turvey, MPH
Contact
cturvey@mathematica-mpr.com
734-205-3145
Jill Berk, PhD
principal investigator · Mathematica Policy Research, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion